Tag: haemodialysis

Pursuit Vascular gets CE mark for ClearGuard HD haemodialysis catheter caps

Pursuit Vascular, Inc., manufacturer of ClearGuard HD Antimicrobial Barrier Caps, has announced that the company has received both (CE) Mark and Medical Device Single...

Comparing and contrasting surgically-created AVFs with those made by endovascular means

 Nicholas Inston (Birmingham, UK) tells Vascular News at LINC 2019 about the exciting field of percutaneous arteriovenous fistula (AVF) creation, the main devices and...

Japanese study investigates new device for accurate haemodialysis catheter placement

Researchers at Okayama University report in The Journal of Vascular Access the use of a supporting device for accurately placing haemodialysis catheters in dialysis...

FDA approves Ellipsys Vascular Access System for non-surgical dialysis fistula creation

Ellipsys Vascular Access System (Avenu Medical) has been granted De Novo marketing authorisation from the Food and Drug Administration (FDA). Ellipsys is a minimally-invasive...

everlinQ endoAVF receives FDA de novo marketing approval

everlinQ endoAVF System (TVA Medical) is now approved by the US Food and Drug Administration for de novo marketing. This innovative, minimally invasive technology...

Humacyte appoints Jeffrey Lawson as president and CEO

Humacyte, an innovator in biotechnology and regenerative medicine, has announced that Jeffrey Lawson has been appointed president and chief executive officer. The former chairman...

New data on quality of life and cost savings for everlinQ...

A recent healthcare analysis shows that a novel, catheter-based endovascular system for creating haemodialysis access offers quality-of-life benefits and cost savings compared to the...

Meta-analysis shows positive experience for patients who received an endovascular arteriovenous...

An international meta-analysis of clinical experience in patients who received an endovascular arteriovenous fistula (endoAVF) for haemodialysis access was presented at Leipzig Interventional Course...
VasQ

First patients enrolled in US pivotal trial of the VasQ device

The first patients have been enrolled in the US FDA pivotal study of VasQ (Laminate Medical Technologies), an implanted blood vessel external support device...
SAVE-US trial

Bluegrass Vascular announces strategic relationship with Merit Medical

Bluegrass Vascular Technologies is entering into a strategic relationship with Merit Medical Systems. The agreement will streamline European distribution of the recently CE mark-approved Surfacer Inside-Out...

Promising results with novel external pneumatic device for fistula maturation

Renal failure affects millions of patients worldwide, with many renal failure patients progressing to end-stage renal disease, requiring dialysis treatment. Dialysis options include central...

Mechanical approaches to improving AV fistula outcomes

Although arteriovenous (AV) fistulae are considered the gold standard for vascular access for haemodialysis and have a low rate of complications and improved longevity...

Tunneled cuffed dialysis catheters: Why does the catheter’s tip matter?

A tunneled catheter remains the most common access in patients initiating haemodialysis.1 This is most likely because the catheters are ready to use immediately...

Flow Forward reports Arteriovenous Fistula Eligibility system data

Flow Forward Medical has announced the completion of a preclinical study and a computational fluid dynamics study supporting continued development of the company's Arteriovenous...

New developments in dialysis grafts

With the rising incidence of haemodialysis worldwide, there is an ever-increasing need for creative, durable means of access. The National Kidney Foundation and Centers...